Attachment
CONTINUUM OF CARE
|
Voluntary, Confidential Counselling and testing—
including lab
facilities
| Psycho-
social
support
| Diet and
nutrition |
Local remedies for
Ols |
Basic Ol
treatment and
prophylaxis-with lab
and monitoring services
e.g. TB
| Mother-to-child transmission prevention—with pre-and
post-natal services
| Palliative care | Complex Ol
treatments (antibiotics and anti
fungals e.g
fluconazole)
| Anti retroviral
treatment
with lab,
monitoring and clinical
expertise
|
|
| Medium | Cheap
| Cheap | Cheap
| Medium | Medium-
Expensive
| Medium | Medium-
Expensive
| Expensive |
|
| Community capacity building— eg treatment advocates, self-help groups, community-based care programmes
|
|
| Build local health infrasructure
|
|
| Increase community awareness and treatment literacy eg importance of adherence
|
|
Notes:
1. Current discussions regarding the price of a range
of ARVs and OI treatment of drugs (eg fluconazole) make it difficult
to attach figures to the cost of drug provision. The indicative
cost bands above suggest price ranges that include product cost
and implementation costs.
2. Building health infra-structure and community capacity
are critical elements in developing a care continuum. Governments,
international donors and local communities all have key roles
and responsibilities in this development. Private sector and employer
provision may also be important in broadening access to care.
3. For estimates of cost of drug treatment see:
Foreman, M (2000), Beyond our Means? The Cost of Treating HIV/AIDS
in the Developing World. Panos: London Gilks et al (1998),
Care and Support for People with HIV/AIDS in Resource-Poor
Settings. DFID: London.
| 
